Nuvo Pharmaceuticals, Inc. Logo Image

Nuvo Pharmaceuticals, Inc.

Nuvo Pharmaceuticals, Inc. Banner Image

Most Recent Annual Report

2017 Annual Report

Nuvo Pharmaceuticals, Inc.

Nuvo Pharmaceuticals, Inc. has reached its limit for free report views.

Nuvo Pharmaceuticals, Inc. does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.

Archived Annual Reports

  • Nuvo Pharmaceuticals, Inc.
  • Nuvo Pharmaceuticals, Inc.
  • Nuvo Pharmaceuticals, Inc.

About Nuvo Pharmaceuticals, Inc.

51-200 Employees
Based in Mississauga, Ontario

Nuvo (TSX: NRI; OTCQX: NRIFF) is a globally focused, healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities. Nuvo has four commercial products that are available in a number of countries: Pennsaid® 2%, Pennsaid, Resultz® and the heated lidocaine/tetracaine patch. Nuvo manufactures Pennsaid 2% for the U.S market, Pennsaid for the global market and the bulk drug product for the HLT Patch at its U.S. Food and Drug Administration (FDA), Health Canada and E.U. approved manufacturing facility in Varennes, Québec. The Company’s focus is to maximize the value of Pennsaid 2% and Resultz through out-licensing to commercial partners in international markets and identifying new opportunities to acquire additional, revenue generating or late-stage products or businesses to further diversify the Company’s existing product portfolio. For additional information, please visit www.nuvopharmaceuticals.com.

Ticker:
NRI
Exchange:
TSX (See More TSX Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol